Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias-Reference-Cited by-同舟云学术

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

Published:2011-02-17 Issue:2 Volume:16 Page:161-171
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Abraham Jean-Daniel¹,Calvayrac-Pawlowski Sophie¹,Cobo Sandra¹,Salvetat Nicolas¹,Vicat Guillaume¹,Molina Laurence¹,Touchon Jacques²,Michel Bernard-François³,Molina Franck¹,Verdier Jean-Michel³,Fareh Jeannette¹,Mourton-Gilles Chantal¹

Affiliation:

1. SysDiag CNRS / Bio-Rad UMR3145, 1682 rue de la Valsiere, Montpellier, France

2. Neurology Service, Gui de Chauliac Hospital, 80 Avenue Augustin Fliche, Montpellier, France

3. Univ. Montpellier 2, Montpellier, F-34095 France; Inserm, U710, Montpellier, F-34095 France; EPHE, Paris, F-75007 France

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.3109/1354750X.2010.536995

Reference63 articles.

1. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders